---
title: primaryÂ myelofibrosisÂ (PMF)
date: "2024-02-26"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[myeloproliferative neoplasms]]

# primaryÂ myelofibrosisÂ (PMF)
- [[myelofibrosis]]
- [[definition of primary myelofibrosis (PMF)]]
- [[etiologies of myelofibrosis]]
- [[clinical manifestations of primary myelofibrosis (PMF)]]
- [[diagnostic evaluation of primary myelofibrosis (PMF)]]
- [[treatment of primary myelofibrosis (PMF)]]

## quick ref

- [Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis - PMC](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399157/)
- [A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis | NEJM](https://www-nejm-org.autorpa.kfsyscc.org/doi/full/10.1056/nejmoa1110557)
